)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
XOMA Corporation (XOMA) investor relations material
XOMA Corporation Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary12 Nov, 2025
Executive summary
Reported net income of $14.1 million for Q3 2025 and $25.6 million for the nine months ended September 30, 2025, reversing prior year losses.
Completed acquisitions of HilleVax and Turnstone, resulting in bargain purchase gains of $17.9 million and $1.8 million, and announced deals for LAVA Therapeutics and Mural Oncology.
Secured royalty interests in early-stage partnered assets via the announced acquisition of LAVA Therapeutics.
Portfolio expanded with new royalty and milestone rights, including significant agreements with BioInvent, Rezolute, Castle Creek, and interests in assets developed by Pfizer and Johnson & Johnson.
Received $43.9 million in royalties and milestones in the first nine months of 2025, including $14.3 million in Q3.
Financial highlights
Q3 2025 income and revenue were $9.4 million, up from $7.2 million in Q3 2024; nine-month income and revenue were $38.4 million, up from $19.8 million year-over-year.
Net income for Q3 2025 was $14.1 million, compared to a net loss of $17.2 million in Q3 2024; nine-month net income was $25.6 million, versus a net loss of $9.9 million in 2024.
Cash and cash equivalents at September 30, 2025, were $130.6 million, including $85.4 million in restricted cash.
Deployed $25.0 million for asset acquisitions, repurchased 109,170 shares for $2.4 million, and paid $4.1 million in preferred dividends in the first nine months of 2025.
Income from purchased receivables under the EIR method rose to $6.96 million in Q3 2025 and $19.0 million for the nine months, primarily from VABYSMO and IXINITY.
Outlook and guidance
Management expects continued growth in income from VABYSMO and OJEMDA royalties as sales expand.
Anticipates several clinical readouts and regulatory milestones through mid-2026 that could significantly impact business trajectory.
Expects to become self-sustaining from royalties alone in the near term, driven by partner commercialization.
Sufficient liquidity to fund operations and obligations for at least the next year; additional capital may be raised through new ATM agreements.
Strategy for divesting acquired IP assets
Blue Owl Loan repayment strategy
Impact of new US pharma tariffs?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next XOMA Corporation earnings date
Q4 20259 Mar, 2026
Next XOMA Corporation earnings date
Q4 20259 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
XOMA Corporation is a biotechnology company that operates primarily as a royalty aggregator. The company focuses on acquiring the economic rights to potential milestone and royalty payments associated with pre-commercial and commercial-stage therapeutic candidates. XOMA's strategy involves building a diversified portfolio of royalty interests in drugs being developed by other pharmaceutical and biotech companies. This approach allows the company to mitigate risk by spreading its investments across multiple therapeutic areas and stages of development, without bearing the costs of research and development itself. The company is headquartered in Emeryville, California, and its share are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage